Finance

Lists
HIMS:NYSE
Hims & Hers Health Inc
$ 29.67
+1.19%
(+0.35) 1D
$ 28.84
-2.80% (-0.83)
After hours
Closed: 10-р сарын 29, 16:00:08 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
$ 29.26
High
$ 30.13
Low
$ 28.66
Mkt. cap
6.92 тэрбум
Avg. vol.
10.12 сая
Volume
7.52 сая
52-wk high
$ 48.34
52-wk low
$ 13.74
EPS
-$ 0.63
Beta
2.44
Shares outstanding
224.94 сая
No. of employees
2 мян
Open
$ 29.26
High
$ 30.13
Low
$ 28.66
Mkt. cap
6.92 тэрбум
Avg. vol.
10.12 сая
Volume
7.52 сая
52-wk high
$ 48.34
52-wk low
$ 13.74
EPS
-$ 0.63
Beta
2.44
Shares outstanding
224.94 сая
No. of employees
2 мян
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2.44 мян
Founded11-р сар 2017
HeadquartersСан-Франциско, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth care provider
Website-
Analyst ratings
Based on 14 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
11
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current $ 29.67
$ 42.00 (+41.56%)
Average
$ 32.82 (+10.62%)
Lowest
$ 26.00 (-12.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Hold
Maintained
$ 32.00
+7.9%
10/28/2026
Glen Santangelo
Barclays
Buy
Maintained
$ 35.00
+18%
10/29/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
$ 32.00
+7.9%
09/11/2026
Bryan Smilek
J.P. Morgan
Hold
Initiated
$ 32.00
+7.9%
09/11/2026
Brian Tanquilut
Jefferies
Hold
Maintained
$ 31.00
+4.5%
09/03/2026
Justin Patterson
KeyBanc
Hold
Maintained
-
-
09/02/2026
George Hill
Deutsche Bank
Hold
Reiterated
$ 26.00
-12.4%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
$ 30.00
+1.1%
08/11/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
$ 28.00
-5.6%
08/11/2026
Maria Ripps
Canaccord Genuity
Buy
Reiterated
$ 40.00
+34.8%
08/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
$ 42.00
+41.6%
08/11/2026
David Larsen
BTIG
Hold
Reiterated
-
-
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
$ 33.00
+11.2%
08/12/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
-
-
08/11/2026
Oliver Chen
TD Cowen
Hold
Reiterated
$ 25.00
-15.7%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
$ 33.00
+11.2%
05/12/2026
Michael Cherny
Leerink Partners
Hold
Maintained
-
-
04/16/2026
Unknown Analyst
Nephron
Buy
Upgraded
$ 35.00
+18%
03/09/2026
Next call 11 өдрийн дараа
11-р сарын 10. Мя, 00:00
Fiscal period
Q3 2026
- / $ 0.15
Revenue / Est. (USD)
- / 892.77 сая
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
598.98 сая
617.82 сая
608.10 сая
753.21 сая
Cost of goods sold
156.92 сая
173.38 сая
182.82 сая
272.41 сая
Cost of revenue
156.92 сая
173.38 сая
182.82 сая
272.41 сая
Research and development expenses
40.58 сая
40.96 сая
46.94 сая
54.90 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
389.67 сая
386.64 сая
426.37 сая
521.95 сая
Operating expense
430.25 сая
427.60 сая
473.31 сая
576.85 сая
Total operating expenses
587.17 сая
600.99 сая
656.13 сая
849.26 сая
Operating income
11.81 сая
16.83 сая
-48.02 сая
-96.04 сая
Other non operating income
-5.99 сая
-575.00 мян
-18.58 сая
-2.43 сая
EBT including unusual items
12.22 сая
18.35 сая
-101.55 сая
-92.63 сая
EBT excluding unusual items
12.22 сая
21.56 сая
-61.57 сая
-96.22 сая
Income tax expense
-3.55 сая
-2.25 сая
-9.44 сая
-6.34 сая
Effective tax rate
-29.05%
-12.25%
9.29%
6.85%
Other operating expenses
-
-
-
-
Net income
15.77 сая
20.60 сая
-92.12 сая
-86.29 сая
Net profit margin
2.63%
3.33%
-15.15%
-11.46%
Earnings per share
0.28
0.22
-0.19
-0.09
Interest and investment income
8.01 сая
6.80 сая
7.90 сая
6.00 сая
Interest expense
-1.60 сая
-1.50 сая
-2.87 сая
-3.75 сая
Net interest expenses
6.41 сая
5.30 сая
5.03 сая
2.25 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
29.48 сая
34.92 сая
-26.07 сая
-66.57 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс